Anti-CCND2 Antibody

Targeting Cyclin D2 (CCND2), a member of the D-type cyclin family that drives the G1-to-S phase transition by partnering with cyclin-dependent kinases CDK4 and CDK6, this polyclonal reagent from Antibodies.com is raised in rabbit and supplied as an unconjugated 100 µl aliquot. The antibody is validated for Western blot (WB) and immunofluorescence (IF), supporting detection of endogenous CCND2 protein in samples of human, mouse, and rat origin. Researchers studying G1/S checkpoint control, retinoblastoma protein (RB) phosphorylation, or hormone-driven proliferation pathways — including investigations of ovarian granulosa cell biology, neuronal progenitor expansion, and CCND2 dysregulation in mantle cell lymphoma and other B-cell malignancies — can use this reagent to probe cyclin D2 expression in whole-cell lysates or fixed specimens. The polyclonal format yields recognition of multiple epitopes across the CCND2 sequence, which can strengthen signal in denatured WB applications while still permitting spatial localization of cyclin D2 by IF. For reproducible results, store the vial refrigerated at 4 °C, avoid repeated freeze-thaw cycles by aliquoting on first use, and protect from light to preserve antibody activity throughout the shelf life of the product.